Hepatic Insufficiency Global Clinical Trials Review, H1, 2012

Date: April 25, 2012
Pages: 92
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: HE8C0128021EN
Leaflet:

Download PDF Leaflet

Hepatic Insufficiency Global Clinical Trials Review, H1, 2012
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2012" provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Hepatic Insufficiency Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hepatic Insufficiency , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
List of Tables
List of Figures
Introduction
Hepatic Insufficiency
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Braintree Laboratories, Inc.
Clinical Trial Overview of Braintree Laboratories, Inc.
Trius Therapeutics, Inc.
Clinical Trial Overview of Trius Therapeutics, Inc.
Shire-Movetis N.V.
Clinical Trial Overview of Shire-Movetis N.V.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Javelin Pharmaceuticals, Inc. (Inactive)
Clinical Trial Overview of Javelin Pharmaceuticals, Inc. (Inactive)
VIVUS, Inc.
Clinical Trial Overview of VIVUS, Inc.
Taiho Pharmaceutical Co., Ltd.
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd.
Dong-A Pharmaceutical Co., Ltd.
Clinical Trial Overview of Dong-A Pharmaceutical Co., Ltd.
Cephalon, Inc.
Clinical Trial Overview of Cephalon, Inc.
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Boehringer Ingelheim GmbH
Clinical Trial Overview of Boehringer Ingelheim GmbH
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Huashan Hospital
Clinical Trial Overview of Huashan Hospital
Copenhagen University Hospital Gentofte
Clinical Trial Overview of Copenhagen University Hospital Gentofte
Aarhus University
Clinical Trial Overview of Aarhus University
Asan Medical Center
Clinical Trial Overview of Asan Medical Center
The University of Edinburgh
Clinical Trial Overview of The University of Edinburgh
McGill University Health Center
Clinical Trial Overview of McGill University Health Center
Rigshospitalet
Clinical Trial Overview of Rigshospitalet
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, BRIC Countries, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, G7 Countries, 2012*
Hepatic Insufficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, E7 Countries, 2012*
Hepatic Insufficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Braintree Laboratories, Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Trius Therapeutics, Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire-Movetis N.V., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Javelin Pharmaceuticals, Inc. (Inactive), 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by VIVUS, Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Pharmaceutical Co., Ltd., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital Gentofte, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2012*

LIST OF FIGURES

Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, G7 Countries (%), 2012*
Hepatic Insufficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, E7 Countries (%), 2012*
Hepatic Insufficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Hepatitis B Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 81 pages
Hepatitis C Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 84 pages
Hepatitis A Global Clinical Trials Review, Q2, 2011 US$ 1,000.00 Jun, 2011 · 46 pages
Hepatitis B Global Clinical Trials Review, H2, 2014 US$ 2,500.00 Nov, 2014 · 134 pages
Hepatitis A Global Clinical Trials Review, H1, 2013 US$ 2,500.00 Jun, 2013 · 93 pages

Ask Your Question

Hepatic Insufficiency Global Clinical Trials Review, H1, 2012
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: